CREO.LSE Creo Medical Group PLC

Healthcare Health Care Equipment & Supplies London Exchange
0.1125 GBX
Close of Nov 3, 2026
9.50 18.50
Market cap
GBX 50.5M
P/E
-
P/B
1.06x
ROE
-59.8%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is CREO.LSE undervalued?

Graham number

The Graham number of Creo Medical Group PLC cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Creo Medical Group PLC fundamental analysis

No fundamental analysis for Creo Medical Group PLC yet.

Creo Medical Group PLC stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Creo Medical Group PLC

Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom. It develops CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with controllable devices delivered through an endoscope. It also offers Speedboat Inject, an energy multimod…

Full company profile